Cerecor Inc (CERC) Director Buys $12,394.80 in Stock

Cerecor Inc (NASDAQ:CERC) Director Armistice Capital, Llc purchased 2,504 shares of the business’s stock in a transaction on Friday, May 10th. The stock was bought at an average cost of $4.95 per share, for a total transaction of $12,394.80. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Armistice Capital, Llc also recently made the following trade(s):

  • On Monday, May 13th, Armistice Capital, Llc acquired 12,587 shares of Cerecor stock. The stock was acquired at an average price of $4.85 per share, for a total transaction of $61,046.95.
  • On Wednesday, March 27th, Armistice Capital, Llc acquired 10,000 shares of Cerecor stock. The stock was acquired at an average price of $5.48 per share, for a total transaction of $54,800.00.
  • On Monday, March 25th, Armistice Capital, Llc acquired 13,762 shares of Cerecor stock. The stock was acquired at an average price of $5.40 per share, for a total transaction of $74,314.80.
  • On Friday, March 8th, Armistice Capital, Llc acquired 4,000 shares of Cerecor stock. The stock was acquired at an average price of $5.46 per share, for a total transaction of $21,840.00.
  • On Wednesday, March 6th, Armistice Capital, Llc acquired 125,486 shares of Cerecor stock. The stock was acquired at an average price of $5.50 per share, for a total transaction of $690,173.00.

Shares of NASDAQ CERC traded up $0.08 during midday trading on Friday, reaching $5.26. The company’s stock had a trading volume of 510 shares, compared to its average volume of 84,332. The company has a current ratio of 0.95, a quick ratio of 0.91 and a debt-to-equity ratio of 0.62. Cerecor Inc has a fifty-two week low of $2.71 and a fifty-two week high of $7.65.

Cerecor (NASDAQ:CERC) last posted its quarterly earnings data on Thursday, May 9th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.16) by $0.03. The company had revenue of $5.41 million for the quarter, compared to the consensus estimate of $4.85 million. Cerecor had a negative net margin of 226.50% and a negative return on equity of 120.67%. As a group, research analysts predict that Cerecor Inc will post -0.72 EPS for the current fiscal year.

A number of analysts have recently issued reports on the stock. HC Wainwright set a $11.00 price objective on shares of Cerecor and gave the company a “buy” rating in a report on Wednesday, April 17th. LADENBURG THALM/SH SH reiterated a “buy” rating and issued a $8.00 price objective on shares of Cerecor in a report on Monday. ValuEngine downgraded shares of Cerecor from a “strong-buy” rating to a “buy” rating in a report on Wednesday, May 1st. Maxim Group reiterated a “buy” rating and issued a $10.00 price objective on shares of Cerecor in a report on Friday, May 10th. Finally, TheStreet upgraded shares of Cerecor from a “d” rating to a “c-” rating in a report on Wednesday, January 30th. Four research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $9.67.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Opaleye Management Inc. increased its holdings in Cerecor by 5.2% during the first quarter. Opaleye Management Inc. now owns 2,300,000 shares of the company’s stock worth $13,432,000 after buying an additional 114,464 shares during the last quarter. Prosight Management LP acquired a new position in Cerecor during the fourth quarter worth $994,000. Geode Capital Management LLC increased its holdings in Cerecor by 50.7% during the fourth quarter. Geode Capital Management LLC now owns 94,990 shares of the company’s stock worth $306,000 after buying an additional 31,951 shares during the last quarter. Vanguard Group Inc increased its holdings in Cerecor by 10.1% during the third quarter. Vanguard Group Inc now owns 87,929 shares of the company’s stock worth $411,000 after buying an additional 8,094 shares during the last quarter. Finally, Spark Investment Management LLC increased its holdings in Cerecor by 60.5% during the first quarter. Spark Investment Management LLC now owns 83,000 shares of the company’s stock worth $484,000 after buying an additional 31,290 shares during the last quarter. Institutional investors and hedge funds own 50.28% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Modern Readers and is owned by of Modern Readers. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://www.modernreaders.com/news/2019/05/17/cerecor-inc-cerc-director-buys-12394-80-in-stock.html.

About Cerecor

Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Ulesfia, Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension, as well as Flexichamber a medical device.

Recommended Story: What is Cost of Capital?

Insider Buying and Selling by Quarter for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.